|
|
|
41
|
4144V
|
VOLTAREN SR 75MG TAB (NVS) DICLOFENAC SO (C)
|
DICLOFENAC SODIUM
|
VOLTAREN SR
|
20'S
|
C
|
27.73
|
1.3863
|
TAB
|
0
|
BOX
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
|
28080492
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
42
|
4144V
|
VOLTAREN 75MG SR TAB (NVS) DICLOFENAC SODIUM
|
DICLOFENAC SODIUM
|
VOLTAREN
|
20'S
|
C
|
27.73
|
1.39
|
TAB
|
28
|
BLIS
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
AVENTA BARBADOS
|
|
28080492
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
6
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
40
|
41458
|
ACULAR LS 0.4% EYE DR (ALL/COL) KETOROLAC
|
KETOROLAC
|
ACULAR LS
|
5ML
|
C
|
26.64
|
26.64
|
EYE DROP
|
0
|
BOTT
|
ALL
|
ALLERGAN INTERNATIONAL
|
COL
|
COLLINS LTD
|
|
520820
|
EENT NSAID
|
2022-04-01
|
2024-03-31
|
|
OPHTHALMIC
|
0
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|
|
|
|
41
|
41458
|
ACULAR LS 0.4% EYE DR (ALL) KETOROLAC (C)
|
KETOROLAC
|
ACULAR LS
|
5ML
|
C
|
26.64
|
26.6396
|
BOTT
|
0
|
BOTT
|
ALL
|
ALLERGAN INTERNATIONAL
|
COL
|
COLLINS LTD
|
|
5208
|
EENT ANTI-INFLAMMATORY AGENTS
|
2024-04-01
|
2026-03-31
|
|
OPHTHALMIC
|
0
|
EENT ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
42
|
41458
|
ACULAR LS 0.4% EYE DR (ALL) KETOROLAC
|
KETOROLAC
|
ACULAR LS
|
5ML
|
C
|
26.64
|
26.64
|
BOTT
|
0
|
BOTT
|
ALL
|
ALLERGAN INTERNATIONAL
|
COL
|
AVENTA BARBADOS
|
|
5208
|
EENT ANTI-INFLAMMATORY AGENTS
|
2026-04-01
|
2028-03-31
|
|
OPHTHALMIC
|
0
|
EENT ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
40
|
4145AB
|
NEVANAC 0.1% EYE DR (NVS/COL) NEPAFENAC
|
NEPAFENAC
|
NEVANAC
|
5ML
|
C
|
16.55
|
16.55
|
EYE DROP
|
0
|
BOTT
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
|
520820
|
EENT NSAID
|
2022-04-01
|
2024-03-31
|
|
OPHTHALMIC
|
0
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|
|
|
|
41
|
4145AB
|
NEVANAC 0.1% EYE DR (NVS) NEPAFENAC (C)
|
NEPAFENAC
|
NEVANAC
|
5ML
|
C
|
16.55
|
16.5546
|
BOTT
|
1
|
BOTT
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
|
520892
|
EENT ANTI INFLAMMATORY AGENTS MISCELLANEOUS
|
2024-04-01
|
2026-03-31
|
|
OPHTHALMIC
|
3
|
EENT ANTI INFLAMMATORY AGENTS MISCELLANEOUS
|
|
|
|
|
42
|
4145AB
|
NEVANAC 0.1% EYE DR (NVS) NEPAFENAC
|
NEPAFENAC
|
NEVANAC
|
5ML
|
C
|
16.55
|
16.55
|
BOTT
|
1
|
BOTT
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
AVENTA BARBADOS
|
|
520892
|
EENT ANTI INFLAMMATORY AGENTS MISCELLANEOUS
|
2026-04-01
|
2028-03-31
|
|
OPHTHALMIC
|
3
|
EENT ANTI INFLAMMATORY AGENTS MISCELLANEOUS
|
|
|
|
|
40
|
4145AE
|
NEPAFENAC 0.1% EYE DR (CIR/AHI)
|
NEPAFENAC
|
NEPAFENAC
|
5ML
|
A
|
7.48
|
7.48
|
EYE DROP
|
1
|
BOTT
|
CIR
|
CIRON PHARMA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
520820
|
EENT NSAID
|
2022-04-01
|
2024-03-31
|
|
OPHTHALMIC
|
3
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|
|
|
|
40
|
4145AF
|
DICLOFENAC SOD 0.1% EYE DR (FSB/ATB) DICLOFEN
|
DICLOFENAC SODIUM
|
DICLOFENAC SOD
|
5ML
|
A
|
5.30
|
5.30
|
EYE DROP
|
1
|
BOTT
|
FSB
|
FLAGSHIP BIOTECH
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
520892
|
EENT ANTI INFLAMMATORY AGENTS MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
OPHTHALMIC
|
6
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|
|
|
|
41
|
4145AF
|
DICLOFENAC SODIUM 0.1% EYE DR (FSB)
|
DICLOFENAC SODIUM
|
DICLOFENAC SODIUM
|
5ML
|
A
|
3.04
|
3.0445
|
BOTT
|
1
|
BOTT
|
FSB
|
FLAGSHIP BIOTECH
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
520892
|
EENT ANTI INFLAMMATORY AGENTS MISCELLANEOUS
|
2024-04-01
|
2026-03-31
|
|
OPHTHALMIC
|
6
|
EENT ANTI INFLAMMATORY AGENTS MISCELLANEOUS
|
|
|
|
|
41
|
4145AG
|
NEPATOP FREE 0.1% EYE DR (SYP) NEPAFENAC
|
NEPAFENAC
|
NEPATOP FREE
|
5ML
|
A
|
8.92
|
8.9161
|
BOTT
|
1
|
BOTT
|
SYP
|
SYAASH PHARMACEUTICALS
|
PSB
|
PHARMACEUTICAL SOLUTIONS BARBA
|
|
5208
|
EENT ANTI-INFLAMMATORY AGENTS
|
2024-04-01
|
2026-03-31
|
|
OPHTHALMIC
|
3
|
EENT ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
42
|
4145AG
|
NEPATOP FREE 0.1% EYE DR (SYP) NEPAFENAC
|
NEPAFENAC
|
NEPATOP FREE
|
5ML
|
A
|
9.11
|
9.11
|
BOTT
|
1
|
BOTT
|
SYP
|
SYAASH PHARMACEUTICALS
|
PSB
|
PHARMACEUTICAL SOLUTIONS BARBA
|
|
5208
|
EENT ANTI-INFLAMMATORY AGENTS
|
2026-04-01
|
2028-03-31
|
|
OPHTHALMIC
|
3
|
EENT ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
42
|
4145AJ
|
DICLOFENAC SODIUM 0.1% EYE DR (FSB)
|
DICLOFENAC SODIUM
|
DICLOFENAC SODIUM
|
5ML
|
A
|
2.75
|
2.75
|
BOTT
|
1
|
|
FSB
|
FLAGSHIP BIOTECH
|
STO
|
BRYDEN STOKES LTD
|
|
520892
|
EENT ANTI INFLAMMATORY AGENTS MISCELLANEOUS
|
2026-04-01
|
2028-03-31
|
|
OPHTHALMIC
|
6
|
EENT ANTI INFLAMMATORY AGENTS MISCELLANEOUS
|
2026-03-05
|
|
|
|
40
|
41514
|
PARLODEL 2.5MG TAB (BCH/COL) BROMOCRIPTINE
|
BROMOCRIPTINE
|
PARLODEL
|
30'S
|
C
|
19.90
|
0.66
|
TABLET
|
0
|
TAB
|
BCH
|
SANDOZ
|
COL
|
COLLINS LTD
|
|
283620
|
DOPAMINE RECEPTOR AGONIST
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
40
|
41519
|
AAP-BROMOCRIPTINE 2.5MG TAB (APO/COL)
|
BROMOCRIPTINE
|
AAP-BROMOCRIPTINE
|
100'S
|
C
|
44.28
|
0.44
|
TABLET
|
0
|
TAB
|
APO
|
APOTEX INC.
|
COL
|
COLLINS LTD
|
|
283620
|
DOPAMINE RECEPTOR AGONIST
|
2022-04-01
|
2024-03-31
|
Name Change
|
Oral
|
0
|
CENTRAL NERVOUS SYSTEM DRUGS
|
2022-04-04
|
|
|
|
42
|
41519
|
AAP-BROMOCRIPTINE 2.5MG TAB (APO)
|
BROMOCRIPTINE
|
AAP-BROMOCRIPTINE
|
100'S
|
A
|
45.18
|
0.45
|
TAB
|
90
|
BOTT
|
APO
|
APOTEX INC.
|
COL
|
AVENTA BARBADOS
|
|
283620
|
DOPAMINE RECEPTOR AGONIST
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
6
|
DOPAMINE RECEPTOR AGONIST
|
|
|
|
|
40
|
4151H
|
BROMOCRIPTINE 2.5MG TAB (KWA/ATB)
|
BROMOCRIPTINE
|
BROMOCRIPTINE
|
10X10
|
A
|
8.56
|
0.29
|
TABLET
|
90
|
TAB
|
KWA
|
KWALITY PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
283620
|
DOPAMINE RECEPTOR AGONIST
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
41
|
4151J
|
AAP-BROMOCRIPTINE 2.5MG TAB (APO) (C)
|
BROMOCRIPTINE
|
AAP-BROMOCRIPTINE
|
100'S
|
C
|
45.18
|
0.4518
|
TAB
|
90
|
BOTT
|
APO
|
APOTEX INC.
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
283620
|
DOPAMINE RECEPTOR AGONIST
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
DOPAMINE RECEPTOR AGONIST
|
|
|
|
|
41
|
4151K
|
BROMOCRIPTINE 2.5MG TAB (KWA)
|
BROMOCRIPTINE
|
BROMOCRIPTINE
|
30'S
|
A
|
8.32
|
0.2773
|
TAB
|
90
|
BOX
|
KWA
|
KWALITY PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
283620
|
DOPAMINE RECEPTOR AGONIST
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
DOPAMINE RECEPTOR AGONIST
|
|